Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: Nutr Cancer. 2016 Sep 20;68(8):1309–1319. doi: 10.1080/01635581.2016.1224365

Figure 3.

Figure 3

Comparison of prostate benign tissue Ki-67 immunohistochemistry number of positive cells/high-power field (200x, which is 10x objective eyepiece x 20x magnification) level changes between treatment groups. Changes in Ki-67 level from pre- to post-intervention between treatment groups were compared using mixed effect model. Values shown indicate least-squares means of (LSMEANS ± SE) pre-to-post change of Ki-67 level by treatment group.